» Articles » PMID: 23089750

High β-lactamase Levels Change the Pharmacodynamics of β-lactam Antibiotics in Pseudomonas Aeruginosa Biofilms

Overview
Specialty Pharmacology
Date 2012 Oct 24
PMID 23089750
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Resistance to β-lactam antibiotics is a frequent problem in Pseudomonas aeruginosa lung infection of cystic fibrosis (CF) patients. This resistance is mainly due to the hyperproduction of chromosomally encoded β-lactamase and biofilm formation. The purpose of this study was to investigate the role of β-lactamase in the pharmacokinetics (PK) and pharmacodynamics (PD) of ceftazidime and imipenem on P. aeruginosa biofilms. P. aeruginosa PAO1 and its corresponding β-lactamase-overproducing mutant, PAΔDDh2Dh3, were used in this study. Biofilms of these two strains in flow chambers, microtiter plates, and on alginate beads were treated with different concentrations of ceftazidime and imipenem. The kinetics of antibiotics on the biofilms was investigated in vitro by time-kill methods. Time-dependent killing of ceftazidime was observed in PAO1 biofilms, but concentration-dependent killing activity of ceftazidime was observed for β-lactamase-overproducing biofilms of P. aeruginosa in all three models. Ceftazidime showed time-dependent killing on planktonic PAO1 and PAΔDDh2Dh3. This difference is probably due to the special distribution and accumulation in the biofilm matrix of β-lactamase, which can hydrolyze the β-lactam antibiotics. The PK/PD indices of the AUC/MBIC and C(max)/MBIC (AUC is the area under concentration-time curve, MBIC is the minimal biofilm-inhibitory concentration, and C(max) is the maximum concentration of drug in serum) are probably the best parameters to describe the effect of ceftazidime in β-lactamase-overproducing P. aeruginosa biofilms. Meanwhile, imipenem showed time-dependent killing on both PAO1 and PAΔDDh2Dh3 biofilms. An inoculum effect of β-lactams was found for both planktonic and biofilm P. aeruginosa cells. The inoculum effect of ceftazidime for the β-lactamase-overproducing mutant PAΔDDh2Dh3 biofilms was more obvious than for PAO1 biofilms, with a requirement of higher antibiotic concentration and a longer period of treatment.

Citing Articles

Mechanisms of antimicrobial resistance in biofilms.

Liu H, Prentice E, Webber M NPJ Antimicrob Resist. 2024; 2(1):27.

PMID: 39364333 PMC: 11445061. DOI: 10.1038/s44259-024-00046-3.


Artificial Intelligence to Close the Gap between Pharmacokinetic/Pharmacodynamic Targets and Clinical Outcomes in Critically Ill Patients: A Narrative Review on Beta Lactams.

Goncalves Pereira J, Fernandes J, Mendes T, Gonzalez F, Fernandes S Antibiotics (Basel). 2024; 13(9).

PMID: 39335027 PMC: 11428226. DOI: 10.3390/antibiotics13090853.


Efficacy and safety of colistin plus beta-lactams for bone and joint infection caused by fluoroquinolone-resistant gram-negative bacilli: a prospective multicenter study.

Mancheno-Losa M, Murillo O, Benavent E, Sorli L, Riera M, Cobo J Infection. 2024; 53(1):359-372.

PMID: 39249177 DOI: 10.1007/s15010-024-02379-7.


Comparative Efficacy of Continuous Ceftazidime Infusion vs. Intermittent Bolus against In Vitro Ceftazidime-Susceptible and -Resistant Biofilm.

El Haj C, Agusti E, Benavent E, Soldevila-Boixader L, Rigo-Bonnin R, Tubau F Antibiotics (Basel). 2024; 13(4).

PMID: 38667020 PMC: 11047404. DOI: 10.3390/antibiotics13040344.


Sensor system for analysis of biofilm sensitivity to ampicillin.

Guliy O, Evstigneeva S, Shirokov A, Bunin V Appl Microbiol Biotechnol. 2024; 108(1):172.

PMID: 38265501 PMC: 10808281. DOI: 10.1007/s00253-023-12831-7.


References
1.
Bagge N, Ciofu O, Hentzer M, Campbell J, Givskov M, Hoiby N . Constitutive high expression of chromosomal beta-lactamase in Pseudomonas aeruginosa caused by a new insertion sequence (IS1669) located in ampD. Antimicrob Agents Chemother. 2002; 46(11):3406-11. PMC: 128714. DOI: 10.1128/AAC.46.11.3406-3411.2002. View

2.
Craig W . Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins. Diagn Microbiol Infect Dis. 1995; 22(1-2):89-96. DOI: 10.1016/0732-8893(95)00053-d. View

3.
Hengzhuang W, Wu H, Ciofu O, Song Z, Hoiby N . In vivo pharmacokinetics/pharmacodynamics of colistin and imipenem in Pseudomonas aeruginosa biofilm infection. Antimicrob Agents Chemother. 2012; 56(5):2683-90. PMC: 3346607. DOI: 10.1128/AAC.06486-11. View

4.
Davies D, Parsek M, Pearson J, Iglewski B, Costerton J, Greenberg E . The involvement of cell-to-cell signals in the development of a bacterial biofilm. Science. 1998; 280(5361):295-8. DOI: 10.1126/science.280.5361.295. View

5.
Nichols W, Evans M, Slack M, Walmsley H . The penetration of antibiotics into aggregates of mucoid and non-mucoid Pseudomonas aeruginosa. J Gen Microbiol. 1989; 135(5):1291-303. DOI: 10.1099/00221287-135-5-1291. View